A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases.

Source:http://linkedlifedata.com/resource/pubmed/id/15711271

Download in:

View as

General Info

PMID
15711271